Beyond HERS: Some (not so) random thoughts on randomized clinical trials

International Journal of Fertility and Women's Medicine

Volumn 46, Issue 2, 2001, Pages 55-59

  Bush, T ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

(HERS); Clinical trials; Confounding factors; HRT; Study designs

Indexed keywords

ESTROGEN; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER PREVENTION; CLINICAL TRIAL; ESTROGEN THERAPY; HEALTH CARE COST; HEART DISEASE; HUMAN; MEDICAL RESEARCH; METHODOLOGY; PRIORITY JOURNAL; RANDOMIZATION;

BREAST NEOPLASMS; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HEART DISEASES; HORMONE REPLACEMENT THERAPY; HUMANS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; TAMOXIFEN; WOMEN'S HEALTH;

EID: 0034917023     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel project P-1 Study
2. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomized chemoprevention trial